The Effectiveness of Amoxicillin and Piperacillin Against Klebsiella pneumoniae in Acute Respiratory Infections at Dr. H. Abdul Moeloek Hospital From 2019 to 2023
DOI:
https://doi.org/10.53089/medula.v16i4.1846Keywords:
Amoxicillin, klebsiella pneumoniae, piperacillinAbstract
Acute respiratory tract infection (ARI) is one of the leading causes of morbidity that often requires antibiotic therapy, with Klebsiella pneumoniae being one of the most commonly found bacterial pathogens and known to have a high level of antibiotic resistance. Irrational use of antibiotics can accelerate the development of resistance, so the effectiveness of antibiotics needs to be evaluated periodically. Amoxicillin and piperacillin are commonly used antibiotics in the management of ARTI. This study aimed to evaluate the effectiveness of amoxicillin and piperacillin against Klebsiella pneumoniae in cases of ARTI at Dr. H. Abdul Moeloek General Hospital from 2019 to 2023. This study is an observational analytical study with a cross-sectional design using secondary data in the form of culture results and antibiotic sensitivity tests from patient medical records. The sampling technique used total sampling with a total of 106 Klebsiella pneumoniae isolates. Data analysis was performed using the Chi-Square test. The results showed that the resistance rate of Klebsiella pneumoniae to amoxicillin was 92.5% with a sensitivity of 7.5%. In contrast, piperacillin showed a higher sensitivity of 58.5% although resistance was still found at 41.5%. Statistical tests showed a significant relationship between the type of antibiotic and the level of bacterial sensitivity (p-value < 0.001). The conclusion of this study indicates that piperacillin is more effective than amoxicillin in the management of ARI caused by Klebsiella pneumoniae and can be considered in the selection of empirical antibiotic therapy.
References
Angelina F, Sari MI, Prabowo A. Gambaran kejadian infeksi saluran pernapasan akut (ISPA) berdasarkan data Riskesdas 2018 di Provinsi Lampung. Jurnal Kesehatan Masyarakat. 2021;16(2):123–131.
Akhavan BJ, Khanna NR, Vijhani P. Amoxicillin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
Bassetti M, Peghin M, Vena A. Treatment of infections due to multidrug-resistant Gram-negative bacteria. Clinical Infectious Diseases. 2022;74(12):2089–2098.
Bush K, Bradford PA. β-lactams and β-lactamase inhibitors: an overview. Clinical Microbiology Reviews. 2020;33(2):1–24.
Carlos MM, Santos JR, Almeida RF. β-lactam antibiotics and their role in respiratory tract infections. Journal of Antimicrobial Chemotherapy. 2023;78(4):987–995.
Hidayati R, Putra AA, Lestari D. Pola penggunaan antibiotik pada pasien ISPA di rumah sakit rujukan. Jurnal Farmasi Klinik Indonesia. 2020;9(3):145–152.
Huttner A, Harbarth S, Nathwani D. Success stories of antimicrobial stewardship. The Lancet. 2020.
Kang CI, Chung DR, Ko KS, Peck KR, Song JH. Risk factors and treatment outcomes of infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Antimicrobial Resistance and Infection Control. 2021;10(1):1–9.
Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global dissemination of carbapenemase-producing Klebsiella pneumoniae. Frontiers in Microbiology. 2021.
Lee YL, Ko WC, Hsueh PR. Piperacillin-based therapy for Gram-negative infections. Journal of Global Antimicrobial Resistance. 2022;29:215–222.
Logan LK, Weinstein RA. The epidemiology of antimicrobial resistance. Journal of Infectious Diseases. 2022.
Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source of antibiotic resistance. Clinical Microbiology Reviews. 2021;34(1):1–29.
Putri NA, Ardiansyah F. Efektivitas piperacillin terhadap bakteri Gram negatif pada infeksi saluran pernapasan. Jurnal Kedokteran Brawijaya. 2021;31(1):45–52.
Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiology and Molecular Biology Reviews. 2020;84(1):1–29.
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. Laporan Nasional Riskesdas 2018. Jakarta: Kemenkes RI; 2019.
Setiawan A. Peningkatan resistensi antibiotik β-laktam pada infeksi saluran pernapasan. Jurnal Mikrobiologi Indonesia. 2019;13(2):89–96.
Suharto R, Wibowo A, Nugroho S. Pola sensitivitas bakteri terhadap antibiotik piperacillin di rumah sakit rujukan. Jurnal Penyakit Dalam Indonesia 2019;6(4):210–217.
Tamma PD, Cosgrove SE, Maragakis LL. Combination therapy for treatment of infections with Gram-negative bacteria. Clinical Microbiology Reviews. 2021.
Troeger, C., Blacker, B., Khalil, I.A., Rao, P.C., Cao, J., Zimsen, S.R.M., Albertson, S.B., Stanaway, J.D., Deshpande, A., Abebe, Z., et al. (2017) Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016. The Lancet Infectious Diseases, 18(11), pp. 1191–1210.
Troeger, C., Forouzanfar, M., Rao, P.C., Khalil, I., Brown, A., Swartz, S., Fullman, N., Mosser, J., Thompson, R., Reiner, R., et al. (2018) Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries. The Lancet, 391(10120), pp. 1191–1210.
Yip K, Gerriets V. Penicillin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
